The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch
Health Populi
JUNE 24, 2021
In the larger public and population health context, on the patient side, we can expect the burden of disease beyond COVID to increase due to postponed care and treatment backlogs. For Medicare Part B programs alone, the drug could consume one-half of the total $57 billion of medicines spending… as much as the U.S. spends on NASA.
Let's personalize your content